We undertook this @-week , open-label , phase @ non-inferiority study at @ sites in eight countries : USA ( @ sites ) , Australia ( @ sites ) , Peru ( @ sites ) , Philippines ( @ sites ) , South Korea ( @ sites ) , UK ( @ sites ) , Israel ( @ sites ) , and Spain ( @ sites ) .